DRAM2, another key factor in the fusion of autophagosomes and lysosomes [28], exhibited upregulated expression (Figure 6B), further confirming that autophagic flux is blocked during combination therapy, leading to the disruption of the tumor cell’s autophagy-mediated protective mechanism. This evidence concerns the gene DRAM2 and neoplasm.